NEW YORK – Regulators in the UK have proposed blocking Illumina's $1.2 billion acquisition of Pacific Biosciences in an effort to preserve competition in the sequencing market in that country, as well as globally.
NEW YORK – Regulators in the UK have proposed blocking Illumina's $1.2 billion acquisition of Pacific Biosciences in an effort to preserve competition in the sequencing market in that country, as well as globally.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.